Hadassah On Call: New Frontiers in Medicine
,
Season
7
,
Episode
12

The Skinny on GLP-1s & Diabetes

From genetics to lifestyle, and breakthrough GLP-1 medications, Dr. Avivit Cahn, head of the Diabetes and Metabolism Unit at Hadassah Hospital Ein Kerem breaks down diabetes in our newest podcast episode.

LISTEN NOW

Watch This Episode

IN THIS Episode
Guests

Dr. Avivit Cahn

Area of specialty
Episode Transcript

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C
Text link

Bold text

Emphasis

Superscript

Subscript

Lorem ipsum

Lorem ipsum

About this episode

Are Ozempic, Wegovy and Mounjaro the miracle weight-loss drugs everyone seems to be talking about? Can diabetes actually be reversed? And is eating well and exercising enough to keep us healthy as we age?

In the latest episode of Hadassah On Call: New Frontiers in Medicine, host Maayan Hoffman sits down with Dr. Avivit Cahn, head of the Diabetes and Metabolism Unit at the Hadassah Hospital Ein Kerem to explore the science behind diabetes, obesity and the new generation of weight-loss medications.

While health experts have always promoted moderation, movement and healthy eating, the growing popularity of weight-loss injections has raised questions about whether medicine is changing the rules.

Dr. Cahn believes these medications represent a major breakthrough but warns that they are not a shortcut to good health.

"It's a medication. It has a lot of potential to do damage," she says, emphasizing the importance of medical supervision, proper nutrition and long-term lifestyle changes.

At the same time, Dr. Cahn wants to challenge the idea that people who need medication have somehow failed to take care of themselves.

"It's not a failure when you've got to [take] medication," she says. "Diabetes is a progressive disorder. It's also genetically determined."

The conversation also explores why diabetes is becoming increasingly common in Israel, how GLP-1 medications affect hunger and blood sugar, what happens when patients stop taking weight-loss injections and why maintaining muscle mass becomes increasingly important with age.

Dr. Cahn also shares practical advice on preventing diabetes complications, choosing the right exercise, understanding when lifestyle changes alone may not be enough, what modern medicine can do for your metabolism and why healthy habits still matter.

Further Learning:


‍

Hadassah On Call: New Frontiers in Medicine is a production of Hadassah, The Women's Zionist Organization of America. Hadassah enhances the health of people around the world through medical education, care and research innovations at the Hadassah Medical Organization. For more information on the latest advances in medicine, please head over to hadassah.org.

This episode includes promotion for Hadassah Lifechanging

Hadassah is lifechanging. Led by women, rooted in Jewish values and with a commitment to Israel and all of its people, Hadassah works every day to bring healing where it's needed most.

Join us in our mission to advance healthcare, drive medical innovation, empower women and youth and combat hate in the US, in Israel and around the world. Hadassah members are the power behind our lifechanging movement. Join us today and change your life. Hadassah.org/join.

About our guest(s)

Dr. Avivit Cahn is the head of the Diabetes and Metabolism Unit at Hadassah Hospital Ein Kerem. A graduate of the Hadassah Hebrew University of Medicine, she completed her residency and fellowship at the school. Dr. Cahn has led and participated in multiple clinical trials, including SAVOR-TIMI 53, and DECLARE-TIMI-58. She has led multiple sub-analyses of these studies including analysis of safety outcomes and outcomes in the elderly in the DECLARE-TIMI-58. Her research interests include big data and digital health, monogenic diabetes and diabetic foot complications, and she has published extensively on these topics.

She is also currently the Head of the Israeli Diabetic Foot and Wound Healing Society and  has authored over 80 publications and book chapters.  Dr. Cahn is a reviewer for multiple diabetes journals and is on the editorial board of Diabetes/Metabolism Research and Reviews. She has lectured at multiple forums and served on numerous advisory boards.

Stay up to date with Hadassah

Subscribe to Hadassah On Call Podcast Monthly Newsletter

By completing this form, I agree to receive occasional emails per the terms of Hadassah privacy statement

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.